Wancheng Guo

Title: Wancheng Guo: Innovator in Pharmaceutical Chemistry

Introduction

Wancheng Guo is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative crystalline forms and processes for drug preparation. With a total of 2 patents, Guo's work is recognized for its potential impact on the pharmaceutical industry.

Latest Patents

Guo's latest patents include the invention of crystalline forms of Acalabrutinib. This invention provides specific crystalline forms, including Acalabrutinib Form APO-I, a co-crystal of Acalabrutinib and urea; APO-II, a co-crystal of Acalabrutinib and nicotinamide; APO-III, a co-crystal of Acalabrutinib and L-sorbitol; APO-IV, a crystalline form of Acalabrutinib; and APO-V, a co-crystal of Acalabrutinib and urea. Additionally, he has developed processes for the preparation of Ribociclib and its intermediates, which are crucial for the synthesis of this important pharmaceutical compound.

Career Highlights

Wancheng Guo is currently employed at Apotex Inc., a leading global pharmaceutical company. His work at Apotex has allowed him to focus on innovative drug formulations and processes that enhance the efficacy and safety of medications.

Collaborations

Guo has collaborated with several talented individuals in his field, including Kangying Li and Fabio E S Souza. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Wancheng Guo's contributions to pharmaceutical chemistry through his patents and work at Apotex Inc. highlight his role as an influential inventor. His innovative approaches to drug formulation and preparation processes are paving the way for advancements in the pharmaceutical industry.